Capital Fund Management S.A. Sage Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.58 - $17.9 $670,676 - $1.13 Million	63,391 Added 47.61%	196,543 $2.13 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $1.12 Million - $1.62 Million	60,246 Added 82.64%	133,152 $2.5 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $801,887 - $1.04 Million	46,894 Added 180.28%	72,906 $1.58 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $100,181 - $292,949	5,981 Added 29.86%	26,012 $535,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $70,243 - $102,885	-1,728 Reduced 7.94%	20,031 $941,000
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $196,412 - $245,423	5,270 Added 31.96%	21,759 $913,000
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $171,948 - $232,877	5,340 Added 47.9%	16,489 $628,000
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $742,795 - $995,685	-23,011 Reduced 67.36%	11,149 $437 Million
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $616,503 - $851,051	-22,402 Reduced 39.61%	34,160 $1.1 Million
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $606,860 - $903,275	-19,761 Reduced 25.89%	56,562 $1.87 Million
Q4 2021 Feb 10, 2022	BUY	$37.06 - $47.11 $394,651 - $501,674	10,649 Added 16.21%	76,323 $3.25 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $497,734 - $709,265	12,363 Added 23.19%	65,674 $2.91 Million
Q2 2021 Aug 12, 2021	SELL	$54.88 - $79.29 $549,842 - $794,406	-10,019 Reduced 15.82%	53,311 $3.03 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $3.72 Million - $5.09 Million	52,590 Added 489.66%	63,330 $4.74 Million
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $316,640 - $482,794	-5,421 Reduced 33.54%	10,740 $929,000
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $422,610 - $1.25 Million	16,161 New	16,161 $464,000
Q2 2019 Aug 12, 2019	SELL	$157.85 - $183.09 $204,731 - $237,467	-1,297 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $115,861 - $212,254	1,297 New	1,297 $206,000
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $466,339 - $589,491	-3,065 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $186,106 - $512,897	3,065	3,065 $505,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account